ETF Evaluator:
Portfolio Bldg Blck Wld Phrm &BtchIdxETF ()
Follow This ETF
(as of Aug 26)
Best Performing in Health Over the Last Year
| 129.4% | Virtus LifeSci Biotech Clinical Trls ETF (BBC) |
| 94.1% | ALPS Medical Breakthroughs ETF (SBIO) |
| 88.4% | F/m Emerald Life Sciences Innovation ETF (LFSC) |
| 72.5% | State Street® SPDR® S&P® Biotech ETF (XBI) |
| 65.8% | State Street® SPDR® S&P® PhrmctlsETF (XPH) |
Risk
Index
Risk
Index
ETF Details
Portfolio Bldg Blck Wld Phrm &BtchIdxETF Overview
Portfolio Bldg Blck Wld Phrm &BtchIdxETF (PBPH) is a passively managed Sector Equity Health exchange-traded fund (ETF). Portfolio Building Block ETFs launched the ETF in 2025.
The investment seeks to track the performance, before fees and expenses, of the BITA Global Pharma and Biotech Select Index.
The fund uses a “passive management” approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets in component securities that make up the index. The fund is non-diversified.
About Portfolio Bldg Blck Wld Phrm &BtchIdxETF (PBPH)
There are 2 members of the management team with an average tenure of 0.68 years: Charles Ragauss (2025) and Qiao Duan (2025). Management tenure is more important for actively managed ETFs than passive index ETFs.
The ETF has 1 primary benchmark: BITA Global Pharma & Biotech Sel TR USD index with a weighting of 100%. Portfolio Bldg Blck Wld Phrm &BtchIdxETF has 56 securities in its portfolio. The top 10 holdings constitute 62.0% of the ETF’s assets. The ETF meets the SEC requirement of being classified as a nondiversified fund. The ETF is considered to have an ESG focus with its investment selection and management.
Portfolio Bldg Blck Wld Phrm &BtchIdxETF is part of the Equity global asset class and is within the Sector Equity ETF group. Portfolio Bldg Blck Wld Phrm &BtchIdxETF has 32.5% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 67.2% There is 32.5% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). Portfolio Bldg Blck Wld Phrm &BtchIdxETF has 0.3% of the portfolio in cash.
Assets Under Management
The fund has $952 million in total assets, which is below the $1 billion average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
PBPH Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The Portfolio Bldg Blck Wld Phrm &BtchIdxETF expense ratio is low compared to funds in the Health category. Portfolio Bldg Blck Wld Phrm &BtchIdxETF has an expense ratio of 0.13%, which is 75% lower than its category average, making the fund expense ratio grade a A. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. Portfolio Bldg Blck Wld Phrm &BtchIdxETF has a portfolio turnover rate of 0%, which indicates that it holds its assets around /years. By way of comparison, the average portfolio turnover is 45% for the Health category.
Recently, in the month of July 2026, Portfolio Bldg Blck Wld Phrm &BtchIdxETF returned 0.1%, which earned it a grade of C, as the Health category had an average return of -0.1%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all ETFs in that category.
Portfolio Bldg Blck Wld Phrm &BtchIdxETF has a trailing yield of 0.00%, which is below the 1.10% category average.
The fund normally distributes its income monthly and its capital gains annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
Portfolio Bldg Blck Wld Phrm &BtchIdxETF Grades
Year to date, the ETF has returned 7.7%, 2.0 percentage points worse than the category, which translates into a grade of C.
For more ETF grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about Portfolio Bldg Blck Wld Phrm &BtchIdxETF, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
PBPH Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| PBPH Return (NAV) | 0.1% | 8.6% | na | na | na | na |
| PBPH Return (Price) | 0.0% | 8.5% | na | na | na | na |
| NAV +/- Price Return | 0.074% | 0.013% | na | na | na | na |
| Health Avg | -0.1% | 11.2% | 36.9% | 9.9% | 1.6% | 8.7% |
| PBPH Grade (NAV) | C | D | na | na | na | na |
| +/- Category (NAV) | 0.2% | -2.7% | na | na | na | na |
| PBPH Tax-Cost Ratio | na | na | na | na | na | na |
PBPH Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| PBPH Return (NAV) | 7.7% | na | na | na | na | na | na | na | na | na | na |
| PBPH Return (Price) | 7.7% | na | na | na | na | na | na | na | na | na | na |
| NAV +/- Price Ret | 0.001% | na | na | na | na | na | na | na | na | na | na |
| Health Avg | 9.7% | 21.8% | 0.1% | 2.2% | -16.3% | 4.3% | 30.5% | 25.4% | -1.5% | 26.5% | -10.2% |
| PBPH Grade (NAV) | C | na | na | na | na | na | na | na | na | na | na |
| +/- Category | -2.0% | na | na | na | na | na | na | na | na | na | na |
| Risk Measures | |
| Beta: | na |
| R-Squared: | na |
| Standard Deviation: | na |
| Category Risk Index: | na |
| Category Risk Rating: | |
| Total Risk Index: | na |
| Total Risk Rating: | |
| Portfolio Characteristics | |
| Yield: | -- |
| Total Assets: | $ 952 Mil |
| Share Class Assets: | $ 952 Mil |
| Turnover: | na |
| Expense Ratio: | 0.13% |
| Index Fund: | Yes |
| Index Tracked: | BITA Global Pharma & Biotech Sel TR USD |
| Index Weighting: | 100% |
| Leveraged: | No |
| Socially Responsible Fund: | Yes |
| Capital Gains Distribution Frequency: | Annually |
| Income Distribution Frequency: | Monthly |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 0.7 years | |||
| Average Tenure: 0.7 years | |||
| Managers (Year): Ragauss Charles (2025), Duan Qiao (2025) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 56 |
| % in Top 10 Holdings: | 62.0% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 32.5% |
Portfolio Allocation |
|
| Domestic Stock: | 67.2% |
| Foreign Stock: | 32.5% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.3% |
Purchase Information
| Legal Structure: | Open Ended Investment Company |
| Fund Family: | Portfolio Building Block ETFs |
| Phone Number: | 877-955-2433 |
| Website: | |
| Inception Date: | November 25, 2025 |
Expenses and Fees
| Expense Ratio (%): | 0.13% (Rating: Low) |
| Category Average Expense Ratio (%): | 0.52% |
